Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
ESMO President: What to watch for at ESMO 2021
Prof Solange Peters - ESMO President
ESMO President: What to watch for at ESMO 2021 ( Prof Solange Peters - ESMO President )
17 Sep 2021
Iberdomide in combination with dexamethasone and daratumumab, bortezomib, or car...
Prof Sagar Lonial - Winship Cancer Institute of Emory University, Atlanta, USA
Iberdomide in combination with dexamethasone and daratumumab, bortezomib, or carfilzomib in RRMM patients ( Prof Sagar Lonial - Winship Cancer Institute of Emory University, Atlanta, USA )
14 Sep 2021
Patterns of recurrence after a radical nephroureterectomy in high-risk upper tra...
Dr Alberto Martini - Vita-Salute San Raffaele University, Milan, Italy
Patterns of recurrence after a radical nephroureterectomy in high-risk upper tract urothelial carcinoma ( Dr Alberto Martini - Vita-Salute San Raffaele University, Milan, Italy )
26 Jul 2021
Breast cancer roundup from ASCO 2021
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
Breast cancer roundup from ASCO 2021 ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
18 Jun 2021
Highlights from ASCO 2021
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Highlights from ASCO 2021 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
8 Jun 2021
NIVO plus chemo vs chemo alone as neoadjuvant treatment for patients with resect...
Dr Jonathan Spicer - McGill University, Montreal, Canada
NIVO plus chemo vs chemo alone as neoadjuvant treatment for patients with resectable NSCLC ( Dr Jonathan Spicer - McGill University, Montreal, Canada )
4 Jun 2021
Olaparib improves disease-free survival in high-risk early-stage HER2-negative b...
Prof Andrew Tutt - Institute of Cancer Research, London, UK
Olaparib improves disease-free survival in high-risk early-stage HER2-negative breast cancer with BRCA 1/2 mutations ( Prof Andrew Tutt - Institute of Cancer Research, London, UK )
4 Jun 2021
KEYNOTE-564: Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy f...
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
KEYNOTE-564: Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Jun 2021
Changes in cancer patient management in India during the pandemic
Prof Geetu Bhandoria - Command Hospital, Kolkata, India
Changes in cancer patient management in India during the pandemic ( Prof Geetu Bhandoria - Command Hospital, Kolkata, India )
5 Mar 2021
ERAS in gynaecological oncology from developed to developing countries
Prof Geetu Bhandoria - Command Hospital, Kolkata, India
ERAS in gynaecological oncology from developed to developing countries ( Prof Geetu Bhandoria - Command Hospital, Kolkata, India )
4 Mar 2021
SEMS trial: result of a prospective, multi-institutional phase II clinical trial...
Dr Sia Daneshmand - University of Southern California, Los Angeles, USA
SEMS trial: result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma ( Dr Sia Daneshmand - University of Southern California, Los Angeles, USA )
24 Feb 2021
Re-irradiation in breast cancer
Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium
Re-irradiation in breast cancer ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )
19 Feb 2021